Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
56.94
+0.47 (+0.83%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CVS Health Corp
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
45
46
Next >
CVS Health Is Down 27% This Year. Is the Stock a Buy on the Dip?
November 03, 2023
At recent prices, the healthcare giant offers a 3.5% dividend yield.
Via
The Motley Fool
What 7 Analyst Ratings Have To Say About CVS Health
November 02, 2023
Via
Benzinga
Wait for the New CEO to Get His Feet Wet Before You Trust Too Much in Walgreens' Guidance
November 02, 2023
Walgreens just hired a new CEO, which means any guidance that exists today has minimal value for investors.
Via
The Motley Fool
3 Beaten-Down, High-Yield Dividend Stocks That Wall Street Predicts Could Soar More Than 25% Over the Next 12 Months
November 02, 2023
Analysts view these dividend stocks as great rebound candidates.
Via
The Motley Fool
Why CVS Health Stock Dropped Today
November 01, 2023
The pharmacy chain modestly lowered its full-year outlook despite strong third-quarter results.
Via
The Motley Fool
CVS Health (CVS) Q3 2023 Earnings Call Transcript
November 01, 2023
CVS earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
CVS Health Unusual Options Activity For October 31
October 31, 2023
Via
Benzinga
Earnings Preview: CVS Health
October 31, 2023
Via
Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
CVS Health Unusual Options Activity For October 17
October 17, 2023
Via
Benzinga
CVS Health's Health Services And Pharmacy Benefit Management Business Show Strength In Q3, But Lowers Annual GAAP EPS Outlook
November 01, 2023
CVS Health Corp's (NYSE: CVS) Q3 sales increased 10.6% Y/Y to $89.76 billion, beating the consen
Via
Benzinga
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News'
November 01, 2023
U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision
November 01, 2023
The CNN Money Fear and Greed index remained in the "Fear" zone on Tuesday. U.S. stocks closed higher on Tuesday, ahead of the Federal Reserve's monetary policy decision. The central bank is widely...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Kraft Heinz, Yum China And 3 Stocks To Watch Heading Into Wednesday
November 01, 2023
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Strike Alert 2023: Workers at CVS, Walgreens, Rite Aid Walk Out
October 30, 2023
Workers at pharmacy companies CVS, Walgreens and RiteAid have staged a three-day strike over unsafe and poor working conditions.
Via
InvestorPlace
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
October 30, 2023
GSK (NYSE: GSK) has reportedly taken an early lead in the race for respiratory syncytial virus (RSV) vaccine dominance, surpassing Pfizer Inc (NYSE: PFE), which previously dominated the COVID-19...
Via
Benzinga
Exposures
COVID-19
'Pharmageddon' - Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report
October 30, 2023
Beginning Monday, pharmacy employees from leading chains such as CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and Rite Aid Corp (OTC:
Via
Benzinga
Risk of Eye Infection - FDA Issues Strong Warning on Eye Drops from Major Retailers
October 30, 2023
On Friday, the FDA issued a warning to consumers, cautioning them against the use of certain over-the-coun
Via
Benzinga
Exposures
Product Safety
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
The U.S.
Via
Benzinga
Exposures
Product Safety
Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets
October 27, 2023
It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S....
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 27, 2023
Via
Benzinga
Jim Cramer Wants You To 'Stay Away' From This Energy Corporation: 'I've Got So Many Other Good Oil Companies'
October 27, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said CVS Health Corporation (NYSE: CVS) is a retailer that has a healthcare business. "It’s not a healthcare business that is a retailer, and retail...
Via
Benzinga
2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades
October 26, 2023
You won't have to worry about paying a premium for either one of these stocks -- and they both pay a solid dividend.
Via
The Motley Fool
WBA Stock Jumps On Upgrade, Target Hike. New CEO, 'New Era' Analyst Says
October 23, 2023
JPMorgan expects Walgreens' new CEO to usher in "a new era" for the Dow Jones giant.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Why This Drugstore Will Avoid Rite Aid’s Bankruptcy Fate
October 22, 2023
The top three drugstores are having a meltdown due to pressures. Today, I’ll walk through what those pressures are, each company’s issues, and point out which one of these drugstores is unfairly...
Via
Talk Markets
Topics
Bankruptcy
Exposures
Financial
Legal
CVS Removes Certain Cold, Cough Products With Phenylephrine From Shelves: Report
October 20, 2023
CVS Health Corp (NYSE: CVS) has reportedly decided to remove specific decongestant products from its stores after an advisory by a panel to U.S. health regulators found an ingredient in these products,...
Via
Benzinga
In Need of a Turnaround: Will Walgreens' New CEO Cut or Spare Its High-Yield Dividend?
October 19, 2023
A healthcare and pharmaceutical benefits manager veteran is coming in to lead the turnaround.
Via
The Motley Fool
Mondelez, CVS Health, Shell And A Major Retailer On CNBC's 'Final Trades'
October 18, 2023
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors said Mondelez International, Inc. (NASDAQ: MDLZ), has "fantastic"
Via
Benzinga
Walgreen's Fresh New Lows, Is The Dividend Worth The Ride?
October 16, 2023
Walgreens stock became a clear value play, offering an attractive dividend yield and tailwinds to position it as an industry leaders are two reasons to watch
Via
MarketBeat
Topics
Bonds
Economy
Exposures
Debt Markets
Economy
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
October 16, 2023
Benzinga Bitcoin Spiked On False ETF Approval Rumor
Via
Benzinga
Topics
ETFs
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
45
46
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.